Repository logo
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
Repository logo
    Communities & Collections
    Research Outputs
    Fundings & Projects
    People
    Organizations
    Statistics
  • English
  • 中文
  • Log In
    New user? Click here to register.Have you forgotten your password?
  1. Home
  2. College of Medicine /醫學院
  3. Institute of Medicine/醫學研究所
  4. Exposure to nickel chloride induces epigenetic modification on detoxification enzyme glutathione S‐transferase <scp>M2</scp>
 
  • Details
Options

Exposure to nickel chloride induces epigenetic modification on detoxification enzyme glutathione S‐transferase <scp>M2</scp>

Journal
Environmental Toxicology
Journal Volume
39
Journal Issue
3
Start Page
1729-1736
ISSN
1520-4081
1522-7278
Date Issued
2023-12-05
Author(s)
Yu‐Ting Kang
Wan‐Jung Yang
Hsu Chih Huang
Sheau‐Chung Tang
Jiunn‐Liang Ko  
DOI
10.1002/tox.24055
URI
https://scholars.csmu.edu.tw/handle/123456789/4870
Abstract
<jats:title>Abstract</jats:title>
<jats:p>
Nickel (Ni) is a human carcinogen with genotoxic and epigenotoxic effects. Environmental and occupational exposure to Ni increases the risk of cancer and chronic inflammatory diseases. Our previous findings indicate that Ni alters gene expression through epigenetic regulation, specifically impacting E‐cadherin and angiopoietin‐like 4 (ANGPTL4), involved in epithelial‐mesenchymal transition and migration. GST‐M2, a member of the glutathione S‐transferase (GST) enzyme family, plays a crucial role in cellular defense against oxidative damage and has been increasingly associated with cancer. GST‐M2 overexpression inhibits lung cancer invasion and metastasis in vitro and in vivo. Hypermethylation of its promoter in cancer cells reduces gene expression, correlating with poor prognosis in non‐small‐cell lung cancer patients. The impact of Ni on GST‐M2 remains unclear. We will investigate whether nickel exerts regulatory effects on GST‐M2 through epigenetic modifications. Additionally, metformin, an antidiabetic drug, is being studied as a chemopreventive agent against nickel‐induced damage. Our findings indicate that nickel chloride (NiCl
<jats:sub>2</jats:sub>
) exposure, both short‐term and long‐term, represses GST‐M2 expression. However, the expression can be restored by demethylation agent 5‐aza‐2′‐deoxycytidine and metformin. NiCl
<jats:sub>2</jats:sub>
promotes hypermethylation of the GST‐M2 promoter, as confirmed by methylation‐specific PCR and bisulfite sequencing. Additionally, NiCl
<jats:sub>2</jats:sub>
also influences histone acetylation, and metformin counteracts the suppressive effect of NiCl
<jats:sub>2</jats:sub>
on histone H3 expression. Metformin reestablishes the binding of specificity protein 1 to the GST‐M2 promoter, which is otherwise disrupted by NiCl
<jats:sub>2</jats:sub>
. These findings elucidate the mechanism by which Ni reduces GST‐M2 expression and transcriptional activity, potentially contributing to Ni‐induced lung carcinogenesis.
</jats:p>
SDGs

[SDGs]SDG3

[SDGs]SDG10

Publisher
Wiley
Type
journal-article
Make it your own

DSpace-CRIS can be extensively configured to meet your needs. Decide which information need to be collected and available with fine-grained security. Start updating the theme to match your Institution's web identity.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Cookie settings
  • Privacy policy
  • End User Agreement
  • Send Feedback